Investor Relations

Redpoint Bio is leveraging recent discoveries in the molecular biology of taste to discover and develop novel taste enhancers and aversive taste blockers for the food, beverage and pharmaceutical industries. The Company’s research and development activities are based on the known function and potential modulation of specific genes involved in taste signaling. Redpoint Bio’s food and beverage program is focused on identifying flavor enhancers that improve the taste of existing ingredients, reduce the need for excess sugar and salt, and contribute to the development of healthier, better-tasting foods and beverages. The pharmaceutical program uses a biochemical approach aimed at suppressing the bitterness of medicines, which has the potential to expand the range of formulation options and increase patient compliance.

Stock Information

RPBC - (OTC: BB) 0.48 + 0.04 Sep 4, 2008 11:46 AM

Recent Releases

Sep 3, 2008
Redpoint Bio to Present at the 19th Annual Wall Street Analyst Conference

Aug 8, 2008
Redpoint Bio Reports Second Quarter and Six Month 2008 Results

Events

Nov 12, 2008
Rodman & Renshaw 10th Annual Healthcare Conference

Sep 26, 2008
NJTC Public/Private Company Showcase